Tech Company Financing Transactions
OncoSec Funding Round
On 4/27/2023, OncoSec raised $3.5 million in investment from New Jersey Economic Development Authority.
Transaction Overview
Company Name
Announced On
4/27/2023
Transaction Type
Venture Equity
Amount
$3,490,000
Round
Undisclosed
Proceeds Purpose
OncoSec Medical Incorporated a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
820 Bear Tavern Rd 200
Ewing, NJ 08628
USA
Ewing, NJ 08628
USA
Phone
Website
Email Address
Overview
OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform. Through our proprietary technology, we are working to deliver safe and effective cancer treatments that can provide long-term benefits for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Arch
Chief Financial Officer
George Chi
Browse more venture capital transactions:
Prev: 4/27/2023: Car Space venture capital transaction
Next: 4/27/2023: Openlayer venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs